Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 391 across all filing types
Latest filing 2023-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company Medifron DBT, covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds (CB) for the company Medifron. It details the change in conversion price, the number of convertible shares, the rationale (market price fluctuation), and the calculation methodology. This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2023-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the results of a General Meeting of Shareholders (AGM) for the company Medifron. It details the outcomes of voting on agenda items such as financial statement approval, director appointments, and remuneration limits. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-03-29 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of Medipron. It details the outgoing CEO, the incoming CEO (Oh Tae-seok), the reason for the change (resignation), and the date of the board resolution. This falls directly under the category of board or management changes.
2023-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion, key financial data, and auditor information for the fiscal year. While it contains financial data, it is a standard regulatory disclosure announcement regarding the receipt and submission of the audit report, rather than the full annual report document itself. Therefore, it fits the 'Report Publication Announcement' (RPA) category. FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 26th fiscal year (2022) of Medifron DBT Co., Ltd. It contains comprehensive financial statements, management discussion and analysis, governance information, and operational details. In the context of Korean corporate filings, the '사업보고서' is the equivalent of the US 10-K annual report, as it is the primary annual disclosure document submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2022
2023-03-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.